Literature DB >> 22958601

Alveolar proteinosis in Behçet's disease.

Cuneyt Tetikkurt1, Seza Tetikkurt, Imran Ozdemir, Cigdem Zuhur, Nihal Bayar.   

Abstract

A 51-year-old man with Behçet's disease complained of fever, dry cough and dyspnea during exertion. Chest CT showed ground glass opacities with interstitial septal thickening in both lungs. Bronchoalveolar lavage (BAL) revealed amorphous and lipoproteinaceous material that was periodic acid-Schiff (PAS) stain positive. Transbronchial biopsy specimen demonstrated PAS positive alveolar eosinophilic material consistent with pulmonary alveolar proteinosis. Serum anti-granulocyte-macrophage colony stimulating factor (GM-CSF) antibody was negative. Recent studies have reported anti-GMCSF not present in the the serum of patients with secondary pulmonary alveolar proteinosis (PAP) but they have not reported so in patients with idiopathic PAP. We report a case of alveolar proteinosis in the setting of Behçet's disease with spontaneous remission.

Entities:  

Year:  2010        PMID： 22958601      PMCID： PMC3436630          DOI： 10.1186/2049-6958-5-4-264

Source DB:  PubMed          Journal:  Multidiscip Respir Med        ISSN： 1828-695X


  10 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Serological diagnosis of idiopathic pulmonary alveolar proteinosis.

Authors:  T Kitamura; K Uchida; N Tanaka; T Tsuchiya; J Watanabe; Y Yamada; K Hanaoka; J F Seymour; O D Schoch; I Doyle; Y Inoue; M Sakatani; S Kudoh; A Azuma; T Nukiwa; T Tomita; M Katagiri; A Fujita; A Kurashima; S Kanegasaki; K Nakata
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

Review 3.  Pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Jeffrey A Whitsett; Koh Nakata
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

4.  Pulmonary alveolar proteinosis.

Authors:  S H ROSEN; B CASTLEMAN; A A LIEBOW
Journal:  N Engl J Med       Date:  1958-06-05       Impact factor: 91.245

5.  Pulmonary alveolar proteinosis in a patient with Behcet's disease.

Authors:  Michihiro Uchiyama; Tsuyoshi Nagao; Aritoshi Hattori; Tatsuya Fujii; Toshio Ichiwata; Koh Nakata; Kenzaburo Tani; Takuya Hayashi
Journal:  Respirology       Date:  2008-12-11       Impact factor: 6.424

Review 6.  Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.

Authors:  Isham Huizar; Mani S Kavuru
Journal:  Curr Opin Pulm Med       Date:  2009-09       Impact factor: 3.155

Review 7.  Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review.

Authors:  U B Prakash; S S Barham; H A Carpenter; D E Dines; H M Marsh
Journal:  Mayo Clin Proc       Date:  1987-06       Impact factor: 7.616

Review 8.  Pulmonary alveolar proteinosis: progress in the first 44 years.

Authors:  John F Seymour; Jeffrey J Presneill
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

9.  Pulmonary alveolar lipoproteinosis complicating juvenile dermatomyositis.

Authors:  M P Samuels; J O Warner
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

10.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307
  10 in total
  1 in total

Review 1.  Pulmonary alveolar proteinosis: report of two cases in the West of Ireland with review of current literature.

Authors:  M J McDonnell; C Reynolds; V Tormey; J J Gilmartin; R M Rutherford
Journal:  Ir J Med Sci       Date:  2013-06-08       Impact factor: 1.568
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.